Cleared Traditional

K791325 - AUTOPAK 12 DIGOXIN TEST DELIVERY SYSTEM

K791325 is an FDA 510(k) clearance for AUTOPAK 12 DIGOXIN TEST DELIVERY SYSTEM, manufactured by Micromedic Systems. The device is a Class 2 Toxicology device with product code DPO cleared through the Traditional 510(k) pathway after a 35-day FDA review.

K791325 · Micromedic Systems · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1979
Decision
35d
Days
Class 2
Risk

K791325 is an FDA 510(k) clearance for the AUTOPAK 12 DIGOXIN TEST DELIVERY SYSTEM. Classified as Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep. (product code DPO), Class II - Special Controls.

Submitted by Micromedic Systems (Mchenry, US). The FDA issued a Cleared decision on August 16, 1979 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3320 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Micromedic Systems devices

FDA 510(k) Submission Details - K791325

510(k) Number K791325 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 1979
Decision Date August 16, 1979
Days to Decision 35 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 87d · This submission: 35d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPO Device Classification - Class 2, Special Controls

Product Code DPO Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep.
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DPO Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep.

All 8
Devices cleared under the same product code (DPO) and FDA review panel - the closest regulatory comparables to K791325.
COAT-A-COUNT DIGOXIN RIA
K811932 · Diagnostic Products Corp. · Jul 1981
KALLESTAD QUANTICOAT 125 DIGOXIN
K811776 · Kallestad Laboratories, Inc. · Jul 1981
RIA PHASE DIGOXIN
K800205 · Boehringer Mannheim Corp. · Mar 1980
VENTRE/SEP DIGOXIN RADIOIMMUNOASSAY KIT
K791355 · Ventrex Laboratories, Inc. · Aug 1979
IGOXIN SOLID PHASE RIA
K771638 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Oct 1977
RADIOIMMUNOASSAY DIGOXIN TEST, IN VITRO
K770365 · Travenol Laboratories, S.A. · Feb 1977